EIC Grant Award
Clarity Sensors wins €2.5Mn funding to develop new X-ray detectors to revolutionise medical imaging
Cambridge, UK – 2 April 2025. Clarity Sensors (www.claritysensors.com) has won a €2.5Mn (£2.1Mn) Transition grant from the EU European Innovation Council (EIC). This is Europe’s flagship innovation programme to identify, develop and scale up breakthrough technologies and game changing innovations. EIC Transition is a competitive programme which supports SMEs like Clarity Sensors.
This non-dilutive funding will allow the company to accelerate the development of its ultra-low dose, high-resolution X-ray detectors. These will transform the use of Computed Tomography (CT) for preventative screening, enabling earlier and less invasive disease detection across diseases such as cancer and cardiovascular disease.
Hayden Salway (Chief Executive Officer and Co-Founder), said “CT imaging is a cornerstone of modern medicine, with over 375 million scans performed globally each year. This number is expected to grow rapidly as populations age and healthcare policies increasingly focus on preventative diagnostics. Yet concerns about the radiation exposure from carcinogenic X-rays currently limit the use of CT for widespread disease screening. However, by enabling high-resolution imaging at ultra-low X-ray doses through cutting-edge X-ray detector technologies, more frequent and accessible CT screening will become possible. These will detect diseases at their earliest, most treatable stages, ultimately saving lives and reducing healthcare costs.”
Sam Stranks (Chief Scientific Officer and Co-Founder) added: “Our technology is based on halide perovskites, which continue to surprise us with their performance – first for high-performance energy applications, and now as extremely sensitive detectors for medical imaging. This opens up very exciting avenues towards early-stage disease detection – with potential to transform medical imaging”
Stuart Evans (Executive Chairman and Co-founder) also commented “Clarity Sensors is a child of the pandemic – our first meetings were at the picnic table by the duckpond outside the Cavendish Laboratory because we weren’t able to meet inside. But those challenging times made us realise we wanted to focus on the health sector as our first market opportunity.”
*** ENDS ***
CONTACTS
Hayden Salway, CEO – 07712 121054 or [email protected]
Stuart Evans, Executive Chairman – 07771 966297 or [email protected]
ABOUT: Clarity Sensors is a Cambridge spinout from StranksLab (www.strankslab.com), a leading research group based in the University’s Department of Chemical Engineering and Biotechnology. The company builds on the technology developed through multiple research grants including from the European Research Council, the UK Medical Research Council, the Engineering and Physical Sciences Research Council and Henry Royce Institute.
Prof. Sam Stranks is Professor of Energy Materials and Optoelectronics at the University of Cambridge and leads an academic group which he established in 2017, comprising over 35 current members. Clarity Sensors’ CEO, Dr. Hayden Salway, has been part of Prof. Stranks’ research group since 2020, during which he completed his PhD specialising in the development of next-generation X-ray detector materials. Now, with support from the European Innovation Council, Clarity Sensors is focused on bringing this transformative technology to market, and is actively hiring world-class talent to help shape the future of healthcare.
For more information about the European Innovation Council, please visit: European Innovation Council – European Commission. This year’s Transition competition attracted over 400 entries from over 20 countries, with 40 awards being made to Clarity Sensors and other SMEs.
https://eic.ec.europa.eu/news/european-innovation-council-transition-accelerating-40-groundbreaking-technologies-lab-market-2025-01-22_en
Socials:
LinkedIn – https://www.linkedin.com/company/claritysensors